Skip to main content

Claudia Stremel is local partner in the German Tax Law Practice Group as well as in the German Private Funds Practice Group. She is an expert in national and international tax law and has been working in this field for more than 20 years. Since 2003, she is admitted as a specialist lawyer for tax law (Fachanwältin für Steuerrecht). Claudia advises domestic and international clients, especially from the real estate sector as well as investment funds and investors.

One key focus of her advisory services is offering tax advice on fund structuring and fund investments, particularly in private equity funds, credit funds, and real estate funds. Claudia Stremel has particular expertise in the taxation of real estate and real estate transactions, as well as in real estate transfer tax. She also has extensive experience in advising on structured investment financing, particularly in film and project financing and the related tax issues.

Claudia has been actively engaged in Corporate Responsibility and pro bono advice for several years.

Prior to joining Greenberg Traurig, Claudia worked at Linklaters for over 10 years and at Olswang for seven years.

Concentrations

  • Real Estate Transfer Tax
  • Investment tax law
  • VAT
  • International Taxation
  • Business related Taxes
  • Withholding Taxes
  • Tax transaction structuring

取扱分野

受賞歴・所属団体

  • Listed, The Legal 500 EMEA Guide, Investment Funds, 2025
  • Team Member, Chambers USA Award for Excellence, Real Estate, 2017

学歴・資格・言語

学歴
  • Second Legal State Exam, Berlin/Germany, 1998
  • First Legal State Exam, University of Berlin/Germany, 1996
  • Certified Translator for English and Chinese Language, Johannes Gutenberg-Universität Mainz, Germersheim/Germany, 1990
弁護士資格
  • Germany
  • Specialist lawyer for tax law
言語
  • 英語
  • German

Related Capabilities

Tax Appeals & Legal Issues コーポレート Entertainment, Media & Sports 訴訟 Public Finance & Infrastructure 不動産 不動産ファンド Technology, Media & Telecommunications Real Estate Tax Cross-Border Tax Planning Life Sciences & Medical Technology ファンド・投資運用